{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:38:07Z","timestamp":1783161487600,"version":"3.54.6"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"DOI":"10.1007\/s00063-024-01159-3","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:04:42Z","timestamp":1720602282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["10\u00a0Kernaussagen zur S3-Leitlinie \u201eEpidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie\u201c","Ten key statements of the S3 guideline \u201cEpidemiology, diagnosis, and treatment of adult patients with nosocomial pneumonia\u201d"],"prefix":"10.1007","author":[{"given":"Jessica","family":"Rademacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"1159_CR1","unstructured":"Deutsche Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin e. V. (2024) (DGP). Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/020-013 (Erstellt: 01.2024)"},{"key":"1159_CR2","doi-asserted-by":"publisher","unstructured":"Darie AM, Khanna N, Jahn K, et\u00a0al. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a\u00a0multicentre, randomised controlled trial. Lancet Respir Med. 2022;10(9):877\u201387. https:\/\/doi.org\/10.1016\/s2213-2600(22)00086-8","DOI":"10.1016\/s2213-2600(22)00086-8"},{"key":"1159_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00595-2021","author":"A Salina","year":"2022","unstructured":"Salina\u00a0A, Schumann\u00a0DM, Franchetti\u00a0L et\u00a0al (2022) Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a\u00a0quasi-experimental study. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00595-2021","journal-title":"ERJ Open Res"},{"issue":"6","key":"1159_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cmi.2023.01.009","volume":"29","author":"M Fartoukh","year":"2023","unstructured":"Fartoukh\u00a0M, Nseir\u00a0S, M\u00e9garbane\u00a0B et\u00a0al (2023) Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV\u20112 pneumonia: a\u00a0multicentre randomized controlled trial. Clin Microbiol Infect 29(6):734\u2013743. https:\/\/doi.org\/10.1016\/j.cmi.2023.01.009","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1159_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jinf.2016.11.013","volume":"74","author":"F Sj\u00f6vall","year":"2017","unstructured":"Sj\u00f6vall\u00a0F, Perner\u00a0A, Hylander M\u00f8ller\u00a0M (2017) Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis\u2014A systematic review with meta-analysis and trial sequential analysis. J\u00a0Infect 74(4):331\u2013344. https:\/\/doi.org\/10.1016\/j.jinf.2016.11.013","journal-title":"J Infect"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"101880","DOI":"10.1016\/j.eclinm.2023.101880","volume":"58","author":"MA Daghmouri","year":"2023","unstructured":"Daghmouri\u00a0MA, Dudoignon\u00a0E, Chaouch\u00a0MA et\u00a0al (2023) Comparison of a\u00a0short versus long-course antibiotic therapy for ventilator-associated pneumonia: a\u00a0systematic review and meta-analysis of randomized controlled trials. EClinicalMedicine 58:101880. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101880","journal-title":"EClinicalMedicine."}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01159-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:04:50Z","timestamp":1720602290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01159-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":6,"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01159-3","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"7 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Rademacher: Forschungsunterst\u00fctzung: BMBF, BMG, INSMED, Infectopharm. Vortragst\u00e4tigkeit: AstraZeneca, GSK, Chiesi, Esanum, Novartis, ThermoFisher, MedUpdate, Berlin-Chemie, Boehringer Ingelheim, Pfizer. Beratert\u00e4tigkeit: Shionogi, GSK, GILEAD, ThermoFisher, Advanz; S.\u00a0Kluge: Forschungsunterst\u00fctzung: CytoSorbents, Daiichi Sankyo. Vortragst\u00e4tigkeit: ADVITOS, Biotest, Daiichi Sankyo, Fresenius Medical Care, Gilead, Mitsubishi Tanabe Pharma, MSD, Pfizer, Shionogi, Zoll. Beratert\u00e4tigkeit: ADVITOS, Fresenius, Gilead, MSD, Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}